IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Lagana', Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.212
AS - Asia 1.400
EU - Europa 1.234
SA - Sud America 272
AF - Africa 32
OC - Oceania 2
Totale 5.152
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.149
SG - Singapore 608
CN - Cina 303
IT - Italia 280
PL - Polonia 246
BR - Brasile 228
HK - Hong Kong 163
DE - Germania 156
FI - Finlandia 147
VN - Vietnam 128
GB - Regno Unito 81
IE - Irlanda 61
TR - Turchia 56
RU - Federazione Russa 55
UA - Ucraina 49
CA - Canada 32
SE - Svezia 32
BD - Bangladesh 29
IN - India 29
ID - Indonesia 25
MX - Messico 21
NL - Olanda 20
FR - Francia 19
CZ - Repubblica Ceca 18
AR - Argentina 16
ZA - Sudafrica 15
BE - Belgio 14
JP - Giappone 14
ES - Italia 12
AT - Austria 9
CH - Svizzera 9
EC - Ecuador 9
DZ - Algeria 6
LT - Lituania 6
PT - Portogallo 6
CL - Cile 5
CR - Costa Rica 5
IQ - Iraq 5
MA - Marocco 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
LB - Libano 3
LV - Lettonia 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
MK - Macedonia 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
ZW - Zimbabwe 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 5.152
Salva come PNG Salva come JPEG
Città #
Singapore 274
Warsaw 243
Ashburn 241
Dallas 233
Hong Kong 163
Fairfield 121
New York 106
Los Angeles 104
Helsinki 101
Beijing 96
Chandler 92
Chicago 67
Munich 62
Wilmington 53
Seattle 52
Princeton 45
Istanbul 44
Houston 43
Woodbridge 43
Cambridge 38
Brescia 37
Dalmine 37
Boardman 36
Ho Chi Minh City 36
Jacksonville 36
Turku 35
Buffalo 32
Redondo Beach 30
Secaucus 30
Dublin 27
Moscow 26
Milan 25
Dong Ket 24
Jakarta 24
Salt Lake City 24
Menlo Park 22
San Francisco 22
The Dalles 22
Hanoi 21
West Jordan 20
Des Moines 19
London 19
Shanghai 19
São Paulo 18
Nuremberg 17
Orem 17
Poplar 17
Ann Arbor 15
Brno 15
Naples 15
Santa Clara 15
Stockholm 15
Brussels 14
Boston 13
Brooklyn 13
Elk Grove Village 13
Johannesburg 12
Rio de Janeiro 12
Romola 11
Tampa 11
Lappeenranta 10
Montreal 10
Tokyo 10
Pune 9
Atlanta 8
Biên Hòa 8
Phoenix 8
Turin 8
Brasília 7
Denver 7
Dulles 7
Düsseldorf 7
San Diego 7
Tianjin 7
Toronto 7
Amsterdam 6
Ankara 6
Chennai 6
Dearborn 6
Frankfurt am Main 6
Livorno 6
Manchester 6
Raleigh 6
Rome 6
Sterling 6
Curitiba 5
Da Nang 5
Jinan 5
New Delhi 5
Querétaro 5
São Bernardo do Campo 5
Venice 5
Zhengzhou 5
Calcinate 4
Campinas 4
Caxias do Sul 4
Dhaka 4
Guangzhou 4
Leipzig 4
Mexico City 4
Totale 3.335
Salva come PNG Salva come JPEG
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 361
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 225
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 197
Immunotherapy failure in adrenocortical cancer: where next? 195
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 172
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 161
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 157
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 152
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 145
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 119
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 112
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 111
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 108
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 104
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 103
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 101
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 100
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 97
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 93
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 92
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 89
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 88
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 87
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 87
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 85
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 84
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 82
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 82
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 81
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 81
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 80
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 79
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 79
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 78
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 75
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 74
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 74
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 71
Oncological treatment administration at end of life: a retrospective study 70
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 70
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 68
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 66
The Evolving Treatment Landscape of Medullary Thyroid Cancer 63
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 63
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 61
Adjuvant denosumab for early breast cancer-Evidence and controversy 60
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 54
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 52
null 51
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 42
Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis 41
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 38
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 35
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis 33
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 18
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 12
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study 5
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 4
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 1
Oligometastatic adrenocortical carcinoma: definition and treatment 1
Totale 5.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021286 0 0 0 0 0 63 20 51 31 52 26 43
2021/2022275 20 10 7 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024595 25 19 45 53 55 97 19 32 86 39 15 110
2024/20251.594 51 31 20 266 140 90 114 67 193 90 393 139
2025/20261.792 238 361 376 349 305 163 0 0 0 0 0 0
Totale 5.269